U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry RACEMIC
Molecular Formula C9H16N2O2S
Molecular Weight 216.301
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TAZOLOL

SMILES

CC(C)NCC(O)COC1=NC=CS1

InChI

InChIKey=DREVJBVJBRSSDL-UHFFFAOYSA-N
InChI=1S/C9H16N2O2S/c1-7(2)11-5-8(12)6-13-9-10-3-4-14-9/h3-4,7-8,11-12H,5-6H2,1-2H3

HIDE SMILES / InChI
Molecular Formula C9H16N2O2S
Molecular Weight 216.301
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Description

Tazolol is a selective myocardial beta-blocking agent. Experiments on dogs have shown that this compound could be useful in patients with heart failure due to coronary artery disease. However, information about the current use of tazolol is not available.

Approval Year

Unknown
149,124

Targets

Primary TargetPharmacologyConditionPotency
Adrenergic receptor beta
89
Agonist
2,752

PubMed

Patents

03982010
7
20070116729
163
7951398
20
8062870
2
8637524
4
WO1996002253A1
2
WO2002045693A1
31
WO2010024870A1
59
Substance Class Chemical
Record UNII
B64Q38TX4G
Record Status Validated (UNII)
Record Version
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966